- Home
- WVVI vs MNPR Comparison
WVVI vs MNPR Comparison
Compare WVVI & MNPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVVI
- MNPR
- Stock Information
- Founded
- WVVI 1983
- MNPR 2014
- Country
- WVVI United States
- MNPR United States
- Employees
- WVVI N/A
- MNPR N/A
- Industry
- WVVI Beverages (Production/Distribution)
- MNPR Biotechnology: Pharmaceutical Preparations
- Sector
- WVVI Consumer Staples
- MNPR Health Care
- Exchange
- WVVI Nasdaq
- MNPR Nasdaq
- Market Cap
- WVVI 16.5M
- MNPR 16.3M
- IPO Year
- WVVI N/A
- MNPR 2019
- Fundamental
- Price
- WVVI $3.35
- MNPR $18.30
- Analyst Decision
- WVVI
- MNPR Strong Buy
- Analyst Count
- WVVI 0
- MNPR 3
- Target Price
- WVVI N/A
- MNPR $27.33
- AVG Volume (30 Days)
- WVVI 6.6K
- MNPR 1.5M
- Earning Date
- WVVI 11-12-2024
- MNPR 11-08-2024
- Dividend Yield
- WVVI N/A
- MNPR N/A
- EPS Growth
- WVVI N/A
- MNPR N/A
- EPS
- WVVI N/A
- MNPR N/A
- Revenue
- WVVI $39,259,016.00
- MNPR N/A
- Revenue This Year
- WVVI N/A
- MNPR N/A
- Revenue Next Year
- WVVI N/A
- MNPR N/A
- P/E Ratio
- WVVI N/A
- MNPR N/A
- Revenue Growth
- WVVI N/A
- MNPR N/A
- 52 Week Low
- WVVI $3.31
- MNPR $1.37
- 52 Week High
- WVVI $5.52
- MNPR $38.50
- Technical
- Relative Strength Index (RSI)
- WVVI 43.95
- MNPR 61.87
- Support Level
- WVVI $3.33
- MNPR $16.25
- Resistance Level
- WVVI $3.52
- MNPR $17.79
- Average True Range (ATR)
- WVVI 0.15
- MNPR 2.36
- MACD
- WVVI -0.00
- MNPR 0.02
- Stochastic Oscillator
- WVVI 16.78
- MNPR 65.88
About WVVI Willamette Valley Vineyards Inc.
Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.